These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32977358)

  • 1. Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain.
    Wilkerson JL; Alberti LB; Kerwin AA; Ledent CA; Thakur GA; Makriyannis A; Milligan ED
    Brain Behav; 2020 Dec; 10(12):e01850. PubMed ID: 32977358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripherally administered cannabinoid receptor 2 (CB
    Wilkerson JL; Alberti LB; Thakur GA; Makriyannis A; Milligan ED
    Brain Res; 2022 Jan; 1774():147721. PubMed ID: 34774500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels.
    Wilkerson JL; Gentry KR; Dengler EC; Wallace JA; Kerwin AA; Armijo LM; Kuhn MN; Thakur GA; Makriyannis A; Milligan ED
    Pain; 2012 May; 153(5):1091-1106. PubMed ID: 22425445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
    Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.
    Rahn EJ; Deng L; Thakur GA; Vemuri K; Zvonok AM; Lai YY; Makriyannis A; Hohmann AG
    Mol Pain; 2014 Apr; 10():27. PubMed ID: 24742127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse.
    Lin X; Xu Z; Carey L; Romero J; Makriyannis A; Hillard CJ; Ruggiero E; Dockum M; Houk G; Mackie K; Albrecht PJ; Rice FL; Hohmann AG
    Pain; 2022 May; 163(5):834-851. PubMed ID: 35001054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LFA-1 antagonist BIRT377 reverses neuropathic pain in prenatal alcohol-exposed female rats via actions on peripheral and central neuroimmune function in discrete pain-relevant tissue regions.
    Noor S; Sanchez JJ; Sun MS; Pervin Z; Sanchez JE; Havard MA; Epler LT; Nysus MV; Norenberg JP; Wagner CR; Davies S; Wagner JL; Savage DD; Jantzie LL; Mellios N; Milligan ED
    Brain Behav Immun; 2020 Jul; 87():339-358. PubMed ID: 31918004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal.
    Li AL; Lin X; Dhopeshwarkar AS; Thomaz AC; Carey LM; Liu Y; Nikas SP; Makriyannis A; Mackie K; Hohmann AG
    Mol Pharmacol; 2019 Feb; 95(2):155-168. PubMed ID: 30504240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
    Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
    Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues.
    Vanderwall AG; Noor S; Sun MS; Sanchez JE; Yang XO; Jantzie LL; Mellios N; Milligan ED
    Brain Behav Immun; 2018 Mar; 69():91-112. PubMed ID: 29113923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.
    Deng L; Guindon J; Vemuri VK; Thakur GA; White FA; Makriyannis A; Hohmann AG
    Mol Pain; 2012 Sep; 8():71. PubMed ID: 22998838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.
    Brownjohn PW; Ashton JC
    Neuroscience; 2012 Feb; 203():180-93. PubMed ID: 22210507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy.
    Carey LM; Xu Z; Rajic G; Makriyannis A; Romero J; Hillard C; Mackie K; Hohmann AG
    Pharmacol Res; 2023 Jan; 187():106560. PubMed ID: 36417942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effects.
    Rahn EJ; Thakur GA; Wood JA; Zvonok AM; Makriyannis A; Hohmann AG
    Pharmacol Biochem Behav; 2011 Jun; 98(4):493-502. PubMed ID: 21382397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP-1-regulated TNF-α expression in the dorsal root ganglia and spinal dorsal horn contributes to the pathogenesis of neuropathic pain in rats.
    Gao Y; Bai L; Zhou W; Yang Y; Zhang J; Li L; Jiang M; Mi Y; Li TT; Zhang X; Zhang W; Xu JT
    Brain Behav Immun; 2020 Aug; 88():482-496. PubMed ID: 32283287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia.
    Yang H; Wu L; Deng H; Chen Y; Zhou H; Liu M; Wang S; Zheng L; Zhu L; Lv X
    J Neuroinflammation; 2020 May; 17(1):154. PubMed ID: 32393298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
    Toth CC; Jedrzejewski NM; Ellis CL; Frey WH
    Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the β2-integrin LFA-1, reduces adverse neuroimmune actions in neuropathic susceptibility caused by prenatal alcohol exposure.
    Sanchez JJ; Sanchez JE; Noor S; Ruffaner-Hanson CD; Davies S; Wagner CR; Jantzie LL; Mellios N; Savage DD; Milligan ED
    Acta Neuropathol Commun; 2019 Apr; 7(1):54. PubMed ID: 30961664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms.
    Wen J; Jones M; Tanaka M; Selvaraj P; Symes AJ; Cox B; Zhang Y
    J Neuroinflammation; 2018 Jan; 15(1):9. PubMed ID: 29310667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A
    Kwilasz AJ; Ellis A; Wieseler J; Loram L; Favret J; McFadden A; Springer K; Falci S; Rieger J; Maier SF; Watkins LR
    Brain Behav Immun; 2018 Mar; 69():470-479. PubMed ID: 29366930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.